Axios @axios
At last, researchers have found a drug that can slow the progression of Alzheimer's disease: Eisai's lecanemab. But now, regulators must weigh its relatively modest efficacy against safety risks — including potential brain swelling and bleeding. https://t.co/ioygSbRlkm — PolitiTweet.org
